MTRY NASDAQ
Monterey Bio Acquisition Corporation
1W: +0.0%
1M: -1.4%
3M: -0.1%
1Y: +9.0%
$11.14
Last traded 2023-11-28 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$48.3M
52W Range10.21-12.0
Volume4,235
Avg Volume3,270
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMurat Omur
SectorFinancial Services
IndustryShell Companies
IPO Date2021-11-22
Websitemontereybio.com
17 State Street
New York City, NY 10004
US
New York City, NY 10004
US
917 267 0216
About Monterey Bio Acquisition Corporation
Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combinationâincluding but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizationsâwith companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| NORTHSTAR BIO VENTUR | J-Other | 75,000 | — | 2023-03-09 |
| McKeever William | 0 | — | 2023-03-09 | |
| Satyal Sanjeev | J-Other | 75,000 | — | 2023-03-09 |
| Patel Sandip I | J-Other | 75,000 | — | 2023-03-09 |
| Coleman Chris D. | 0 | — | 2023-03-09 |